about
Biomarkers in autismPerspective Biological Markers for Autism Spectrum Disorders: Advantages of the Use of Receiver Operating Characteristic Curves in Evaluating Marker Sensitivity and SpecificityDevelopmental neurotoxicity - challenges in the 21st century and in vitro opportunitiesReduced sulfate plasma concentrations in the BTBR T+tf/J mouse model of autismCurrent progress and challenges in the search for autism biomarkersQEEG spectral and coherence assessment of autistic children in three different experimental conditions.Use of solid-phase microextraction coupled to gas chromatography-mass spectrometry for determination of urinary volatile organic compounds in autistic children compared with healthy controls.Autism as the Early Closure of a Neuroplastic Critical Period Normally Seen in Adolescence.Measurement in saliva from neurotypical adults of biomarkers pertinent to autism spectrum disorders.Autism biomarkers: challenges, pitfalls and possibilities.The gut: a triggering place for autism - possibilities and challenges.The Prevalence of Autism Spectrum Disorders in West Pomeranian and Pomeranian Regions of Poland.Modeling autism: a systems biology approach.Amniotic fluid inflammatory cytokines: potential markers of immunologic dysfunction in autism spectrum disorders.GC-MS-based urine metabolic profiling of autism spectrum disorders.Combined 1H-NMR and 1H-13C HSQC-NMR to improve urinary screening in autism spectrum disorders.Distinct plasma profile of polar neutral amino acids, leucine, and glutamate in children with Autism Spectrum Disorders.Quantitation of plasma thiamine, related metabolites and plasma protein oxidative damage markers in children with autism spectrum disorder and healthy controls.
P2860
Q21129103-E1988315-0146-4423-A5A2-68B516AD4C6EQ26773383-AFBBCF92-9224-40B4-A5B1-0C41054FE3F3Q28388774-3F058640-9AC7-4647-A63E-F52218FB5982Q28389692-2EF8F02F-6497-4F32-9BED-3944F9D5F635Q28680718-7184E08D-1EC7-473B-A524-DA549321410EQ30419563-1F925196-BE0D-482B-8C37-FBA6FB8208AAQ34420046-8DD8C2AC-E580-4AE2-88A7-2A05F9FE29A7Q37394661-E43F9B6B-9972-4A27-AD5A-4FC3BFFDF881Q37474219-6674B065-4880-4434-82BB-61E49380CE01Q38246388-8384E52C-328A-4EB8-AAB5-AD6F06D1CF62Q39670262-655C3479-4C51-4399-9626-DE202A4E52E6Q40104048-865A5927-3AE9-494A-A4AF-FE8C0F43015BQ42062971-34E5A94F-0B51-47B6-9690-C60F1716C5CDQ44616626-0E826DCA-FD1D-4E6F-B790-509AF5E7E45FQ50301433-23AB1535-2120-4A31-837C-ED2DFDAE1827Q50306889-C1B4AF3E-D488-4564-8986-28392EE307FEQ50310146-BFE19B7B-F1D3-429D-B7A5-F7A30C19C3BCQ50312679-405F7A90-9F83-4D64-84B3-41DE6C152E22
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Theoretical aspects of autism: biomarkers--a review.
@en
Theoretical aspects of autism: biomarkers--a review.
@nl
type
label
Theoretical aspects of autism: biomarkers--a review.
@en
Theoretical aspects of autism: biomarkers--a review.
@nl
prefLabel
Theoretical aspects of autism: biomarkers--a review.
@en
Theoretical aspects of autism: biomarkers--a review.
@nl
P2860
P1476
Theoretical aspects of autism: biomarkers--a review.
@en
P2093
Helen V Ratajczak
P2860
P356
10.3109/1547691X.2010.538749
P577
2011-01-01T00:00:00Z